Year-3 Observational Follow-up of Belimumab Safety (Mortality and Malignancies) in Patients with SLE Who Completed a Phase 4, 52-Week, Randomized, Double-Blind Placebo-Controlled Safety StudySaira Sheikh,Cheng-Chung Wei,Dana Tegzova,William Stohl,Ricardo Acayaba de Toledo,Tamara Mucenic,Mauricio Abello Banfi,Kathleen Maksimowicz-McKinnon,Carlos Abud-Mendoza,Sandra Navarra,Mercedes Garcia,Ignacio Garcia-De La Torre,Regina Kurrasch,Sofia Fernandes,Julia Harris, Saima Muzaffar,Norma Lynn Fox,Andrew Liu,Holly Quasny,David RothARTHRITIS & RHEUMATOLOGY（2021）引用 1|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
